http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016017066-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2aa388e460f6cf478bd46c925c6ab10e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 2014-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fc17d92b4d1cf76582077ad8a093023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82641b75ee1fd98a6d5804984f21af65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d384e234c2035e6255074e288ba650b |
| publicationDate | 2016-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2016017066-A |
| titleOfInvention | Clopidogrel tablets |
| abstract | To provide a solid dosage form capable of reducing the size of a tablet without impairing the chemical and physical stability of clopidogrel hydrogensulfate, which is an antithrombotic drug. A solid dosage form comprising clopidogrel bisulfate aggregates having a particle size distribution such that D10 is not less than 75 microns, wherein the clopidogrel bisulfate aggregates are at least 55% by weight of said solid dosage form. A solid dosage form present in an amount. Preferably, the clopidogrel bisulfate aggregate has a D50 particle size distribution not less than 150 microns, a D90 particle size distribution not greater than 750 microns, and is present in an amount of at least 75% by weight of the solid dosage form. . [Selection figure] None |
| priorityDate | 2014-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.